The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer

被引:23
作者
Miyagi, Motoshi [1 ]
Aoyagi, Keishiro [1 ]
Kato, Seiya [2 ]
Shirouzu, Kazuo [1 ]
机构
[1] Kurume Univ, Dept Surg, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Pathol, Fukuoka 8300011, Japan
关键词
gastric cancer; peritoneal metastasis; TIMP-1; adenovirus vector; MATRIX METALLOPROTEINASES MMPS; TISSUE INHIBITOR; CELLS; INVASION; COLLAGENASE; MECHANISM; DOMAIN;
D O I
10.1007/s10147-006-0616-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. It has become clear in recent years that peritoneal metastasis takes place as the result of a multistep process involving attachment, invasion, proliferation, and angiogenesis. The aim of the present study was to evaluate the suppressive effect of tissue inhibitor of metalloproteinase-1 (TIMP-1) gene transfer on peritoneal dissemination. Methods. We established a high-potential peritoneal metastasis cell line (MKN-45P), using the gastric cancer cell line MKN-45, and developed a peritoneal metastasis model in nude mice. The TIMP-1 gene was transferred to MKN-45 or MKN-45P by adenoviral transfection, and we performed an in vitro invasion assay and an in vivo study, using the peritoneal metastasis model. The TIMP-1 transfected group was compared with a non-virus group and a Lac-Z transfected group. Results. The in vitro invasion assay showed that the number of invasive cells was significantly reduced in the TIMP-1 transfected group compared with that in the non-virus group and the Lac-Z transfected group, Moreover, the in vivo studies showed that the number and the weight of the peritoneal nodes in the TIMP-1 transfected group were significantly less than those in the Lac-Z transfected group, and less than those in the non-viral group. No bloody ascites was recognized in the TIMP-1 transfected group. The mean number of tumor vessels in the non-virus group and the Lac-Z group was significantly higher than that in the TIMP-1 group. Conclusion. TIMP-1 demonstrated an inhibitory effect on angiogenesis, and may be worthwhile investigating for use as a future therapy for peritoneal dissemination.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 43 条
[1]   TARGETED DISRUPTION OF THE TISSUE INHIBITOR OF METALLOPROTEINASES GENE INCREASES THE INVASIVE BEHAVIOR OF PRIMITIVE MESENCHYMAL CELLS DERIVED FROM EMBRYONIC STEM-CELLS INVITRO [J].
ALEXANDER, CM ;
WERB, Z .
JOURNAL OF CELL BIOLOGY, 1992, 118 (03) :727-739
[2]   INHIBITION OF COLLAGENOLYTIC ACTIVITY AND METASTASIS OF TUMOR-CELLS BY A RECOMBINANT HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES [J].
ALVAREZ, OA ;
CARMICHAEL, DF ;
DECLERCK, YA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) :589-595
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]  
DECLERCK YA, 1992, CANCER RES, V52, P701
[5]   Tissue inhibitors of metalloproteases: Regulation and biological activities [J].
Fassina, G ;
Ferrari, N ;
Brigati, C ;
Benelli, R ;
Santi, L ;
Noonan, DM ;
Albini, A .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) :111-120
[6]  
Gomez DE, 1997, EUR J CELL BIOL, V74, P111
[7]   Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J].
GomisRuth, FX ;
Maskos, K ;
Betz, M ;
Bergner, A ;
Huber, R ;
Suzuki, K ;
Yoshida, N ;
Nagase, H ;
Brew, K ;
Bourenkov, GP ;
Bartunik, H ;
Bode, W .
NATURE, 1997, 389 (6646) :77-81
[8]   In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 [J].
Guedez, L ;
Stetler-Stevenson, WG ;
Wolff, L ;
Wang, J ;
Fukushima, P ;
Mansoor, A ;
Stetler-Stevenson, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :2002-2010
[9]   GROWTH-PROMOTING ACTIVITY OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) FOR A WIDE-RANGE OF CELLS - A POSSIBLE NEW GROWTH-FACTOR IN SERUM [J].
HAYAKAWA, T ;
YAMASHITA, K ;
TANZAWA, K ;
UCHIJIMA, E ;
IWATA, K .
FEBS LETTERS, 1992, 298 (01) :29-32
[10]  
HEE JK, 2006, MOL CANCER RES, V4, P209